Susana Arias-Rivas

TL;DR: The detailed clinical picture is described, consisting of a late-onset, slowly progressive cerebellar syndrome with variable eye movement abnormalities and sensorineural hearing loss, and the origin of the founder mutation in Galicia is estimated to have occurred ∼1275 years ago.

TL;DR: Pro-BNP ≥360 pg/mL increases by 5-fold the possibility of detecting AF during follow-up in patients with cryptogenic stroke, and was the only variable independently associated with the risk of developing AF.

TL;DR: According to the etiologic criteria developed, only about 40% patients received a definite diagnosis, while in the remaining patients ICH was attributable to a single possible/probable etiology or to more than one possible/ Probable etiologies.

TL;DR: The modeling of time series showed a distinct falling trend in mortality, with a slight increase in good outcome as well as morbidity in both ischemic and hemorrhagic stroke, which seems to be confirmed for the coming years.

TL;DR: Findings suggest that Treg may participate in the recovery of IS patients and be considered a potential therapeutic target in acute ischemic stroke.